| 标题 |
Efficacy of fruquintinib (F) plus sintilimab (S) versus axitinib (A) or everolimus (E) by scores of IMDC risk factors and PD-L1 expression at baseline in previously treated advanced renal cell carcinoma (RCC): A subgroup analysis of the FRUSICA-2 study |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Clinical Oncology 作者:Kaiwei Yang; Dingwei Ye; Xi Zhang; Xin Yao; Yu Xie; et al 出版日期:2026-05-27 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)